Levosulpiride Generics - Manufacturers & Suppliers
not approved in US/EU; Eastern European nations markets as Levopraid, Neoprad, or as generics.
| Product/Composition:- | Levosulpiride |
|---|---|
| Strength:- | 25 mg, 50 mg, 75 mg, 100 mg |
| Form:- | Oral tablets, capsules |
| Reference Brands:- | not approved in US/EU; Eastern European nations markets as Levopraid, Neoprad, or as generics. |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Levosulpiride, used for GERD, dyspepsia, and psychiatric disorders, is available in oral and injectable forms. Though not FDA-approved in the US, it is sold in select EU regions under brands like Levopraid. B2B platforms offer bulk Levosulpiride from GMP-certified suppliers for international pharmaceutical distribution.
Levosulpiride is a substituted benzamide antipsychotic and prokinetic agent used for dyspepsia, GERD, and psychiatric conditions such as depression and schizophrenia. Available in oral (25 mg, 50 mg, 75 mg) and injectable (25 mg/2 ml, 50 mg/2 ml) forms, Levosulpiride is marketed in select EU regions under brands like Levopraid and Neoprad. While not FDA-approved in the US, it is in demand across Asia, Eastern Europe, and Latin America. Pharma B2B buyers source Levosulpiride for therapeutic areas including GI motility and mood disorders. GMP-compliant manufacturers offer bulk supply solutions for hospitals, clinics, and global distributors.